Georgios Kitsios, MD, PhD
University of Pittsburgh
Research Project:
Lung COVID-19 Interactions with Microbiota and Host (LUCID-IMHO)
Grant Awarded:
- COVID-19 Respiratory Virus Research Award
Research Topics:
- biomarkers
- clinical research
- computational biology
Research Diseases:
- ARDS
- COVID-19
- pneumonia
The sickest patients with COVID-19 require life support on a ventilator to help their breathing while their immune system fights off the virus. About half of COVID-19 patients who end up on a ventilator do not survive, and even those who survive suffer from long-lasting consequences. Investigators to date have focused on how the SARS-CoV-2 virus is cleared from the lungs, and whether an overtly active immune system can at times cause more damage than benefit. However, about 50% of COVID-19 patients on ventilators develop a serious, life-threatening infection, called ventilator-associated pneumonia (VAP), caused by organisms other than SARS-CoV-2. We will investigate how the virus and the immune system interact with microbes in the ventilated lungs of sick patients with COVID-19. Our goal is to define targets for more timely therapeutic and preventive interventions for VAP in vulnerable patients with COVID-19 and similar viral illnesses in future epidemics.
Page last updated: October 3, 2023
A Breath of Fresh Air in Your Inbox
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank You!
You will now receive email updates from the American Lung Association.